20
Samyang Holdings Corporation Gyeonggi-do Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Paclitaxel, Produced by fermentation, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-255 - Rev 02
This Chemical Type CEP, issued on August 12, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1794 associated with this CEP further emphasizes